Two ethnicities one hyaluronic skin booster comparative: a case series
Main Article Content
Keywords
Hyaluronic acid, Skin Aging, Dermal fillers, Skin Hydration, Wrinkle correction, Ethnicity.
Abstract
Aim: to assess the safety and efficacy of Viscoderm® Hydrobooster (VH) in treating skin ageing signs on the face of 10 female subjects from Italy and Oman with diverse features in terms of phenotype, genetics and anthropometry. Methods: two specialists in aesthetic medicine, one from Italy and one from Oman, recruited 5 patients each between 35-65 years old. 1.1 ml of VH were injected during 2 sessions at 60-day intervals, with 0.02 to 0.05 ml of product at each point. Post-treatment evaluation was scheduled at 4 months from baseline, photos were taken before, after each session and at final visit. VAS score ranging from 0 to 10 was recorded after each treatment, physician’s and patient’s GAIS scores ranging from -3 to +3 were provided at second and final visit. Results: GAIS score at second treatment was 2 for 4 patients out of 10 and in 5 out of 10 physicians reports, and 1 in 5 patients and 5 clinicians' reports, with an average value of 1.3 and 1.5 as to patients and specialists, respectively. As for GAIS evaluations at final visit, 8 patients and 8 clinical reports indicate the maximum positive score, with an average value of 2.8 for both patients and specialists, with strong agreement and great satisfaction. Average VAS value reported at baseline was 5.3 (SD 0.94), average VAS score at second treatment decreased at 5 (SD 0.66). Conclusions: in all the cases presented in this study, despite the different ethnicity and ageing features, VH provided deep hydration, increased elasticity, and tissue restructuring, stretching both dynamic and superficial wrinkles, along with improvement of skin defects, such as acne scars, with an early clinical benefit.
References
2. Jones D, Brace C, Jankowiak W, et al. Sexual selection, physical attractiveness, and facial neoteny: cross-cultural evidence and implications [and comments and reply]. Curr Anthropol. 1995; 36(5):723–748.
3. Vashi NA, De Castro Maymone MB, Kundu VR. Aging Differences in Ethnic Skin. J Clin Aesthet Dermatol. 2016; 9(1):31-8.
4. Fink B, Grammer K, Matts P. Visible skin color distribution plays a role in the perception of age, attractiveness, and health in female faces. Evol Hum Behav. 2006; 27(6):433–442.
5. Fink B, Matts PJ, D’Emiliano D, Bunse L, Weege B, Röder S. Colour homogeneity and visual perception of age, health and attractiveness of male facial skin. J Eur Acad Dermatol Venereol. 2012; 26(12):1486–1492.
6. Fink B, Bunse L, Matts PJ, D’Emiliano D. Visible skin colouration predicts perception of male facial age, health and attractiveness. Int J Cosmet Sci. 2012; 34(4):307–310.
7. Matts PJ, Fink B, Grammer K, Burquest M. Color homogeneity and visual perception of age, health, and attractiveness of female facial skin. J Am Acad Dermatol. 2007; 57(6):977–984.
8. IPAPS International Survey on Aesthetics/Cosmetic Procedures Performed in 2020. www.isaps.org
9. Puri P, Nandar S, Kathuria S, Ramesh V. Effects of air pollution on the skin: a review. Indian J Dermatol Venereol Leprol. 2017; 83(4):415–423.
10. Zhang S, Duan E. Fighting against skin aging: the way from bench to bedside. Cell Transplant. 2018; 27(5):729–738.
11. Ghersetich I, Lotti T, Campanile G, Grappone C, Dini G. Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol. 1994; 33(2):119–122.
12. Fore J. A review of skin and the effects of aging on skin structure and function. Ostomy Wound Manage. 2006; 52:24–35; quiz 36–37.
13. Carruthers J, Carruthers A, Humphrey S. Introduction to fillers. Plast Reconstr Surg. 2015; 136(5 Suppl):120S–131S.
14. Ascher B, Bayerl C, Brun P, et al. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines – 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Dermatol. 2011; 10(2):94–98.
15. Hong JY, Choi EJ, Choi SY, Li K, Kim BJ. Randomized, patient/ evaluator-blinded, intraindividual comparison study to evaluate the efficacy and safety of a novel hyaluronic acid dermal filler in the treatment of nasolabial folds. Dermatol Surg. 2018; 44(4):542–548.
16. McCracken MS, Khan JA, Wulc AE, et al. Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthalmic Plast Reconstr Surg. 2006; 22(3):188–191.
17. Baumann L, Weiss RA, Grekin S, et al. Comparison of Hyaluronic Acid Gel With (HARDL) and Without Lidocaine (HAJUP) in the treatment of moderate-to-severe nasolabial folds: a randomized, evaluator-blinded study. Dermatol Surg. 2018; 44(6):833–840.
18. Monheit G, Beer K, Hardas B, et al. Safety and effectiveness of the hyaluronic acid dermal filler VYC-17.5L for nasolabial folds: results of a randomized, controlled study. Dermatol Surg. 2018; 44(5):670–678.
19. Sparavigna A, Tenconi B, Giori AM, Bellia G, La Penna L. Evaluation of the efficacy of Viscoderm Hydrobooster on dynamic and static wrinkles in volunteers with moderate aging/photoaging. Clin Cosmet Investig Dermatol. 2019; 12:81-90.
20. Beatini A, Piersini P, Russo R. “REAL LIFE” efficacy evaluation of a new hyaluronic acid gel suitable for deep hydration and fine wrinkles correction. Aesthetic Medicine. 2019; 5(3):19-24.
21. Wagner JK, Parra EJ, Norton HL, Jovel C, Shriver MD. Skin responses to ultraviolet radiation: effects of constitutive pigmentation, sex, and ancestry. Pigment Cell Res. 2002; 15(5):385–390.
22. Alexis AF, Alam M. Racial and ethnic differences in skin aging: implications for treatment with soft tissue fillers. J Drugs Dermatol. 2012; 11(8):s30–s32; discussion s2.
23. Brissett AE, Naylor MC. The aging African-American face. Facial Plast Surg. 2010; 26(2):154–163.
24. Shaw RB Jr, Katzel EB, Koltz PF, et al. Aging of the facial skeleton: aesthetic implications and rejuvenation strategies. Plast Reconstruct Surg. 2011; 127(1):374–383.
25. McKnight A, Momoh AO, Bullocks JM. Variations of structural components: specific intercultural differences in facial morphology, skin type, and structures. Semin Plast Surg. 2009; 23(3):163–167.
26. Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol. 2002; 46(2 Suppl Understanding):S41–S62.
27. Harris MO. The aging face in patients of color: minimally invasive surgical facial rejuvenation-a targeted approach. Dermatol Ther. 2004; 17(2):206–211.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
